LivingGLP1
Descriptive only

Ovulation

Polycystic ovary syndrome

weeks 12 to 52 (target week 26)Not stated by the trialsDoses of a drug pooledOdds ratio
1
Randomized trials
2
Treatments
60
Participants
7
Events

In plain language

No network meta-analysis was fitted here. The protocol requires at least two trials forming a connected network; this outcome has 1 trial. The trial data below are shown as reported.

Network of trials

Each circle is a treatment; each line joins treatments that were randomized against each other in at least one trial.
LIRA_SCOTHER_ACTIVE_cyproterone_ethinylestradiol
Node area shows participants; line width shows trials comparing two treatments directly. Blue: GLP-1 receptor agonist containing treatments; grey: comparators. Hover over or tab to a node or line for details.

Comparability of the trials

Checked across designs (the set of treatments each trial compares) for eligibility, outcome definition and assessment, and the baseline factors above. Flags point to possible intransitivity; notes describe variation that is not tied to design.

No comparability concerns were found.

Comparability items per trial
Trialtime weeksanalysis setdefinitioninstrumentadjudicatedproportion methodintercurrent events (discontinuation)intercurrent events (rescue)blindingfundingstart yearEligibility
NCT0315100512completersdominant follicle on ultrasound, called ovulation in the abstractnot statednot statednot statednot statednot statedopen_labelnon_industry2017Rotterdam PCOS, BMI 24 kg/m2 or more, age 18 to 50 years

Trial data

What each trial contributes. Arm rows give the arm value with its standard error, or events over participants; contrast rows give the odds ratio on the analysis scale (log) against the trial's first row. Flags mark converted, combined or approximated inputs.
Trial data entering this analysis
TrialArmTreatmentWeekDataValueSEEvents / NFlagsSource
NCT03151005A1OTHER_ACTIVE_cyproterone_ethinylestradiol12arm, responders1 / 30R0007146:Table 1
NCT03151005A2LIRA_SC12arm, responders6 / 30R0007146:Table 1

Rerun this analysis yourself

Remove treatments or trials and refit the frequentist and Bayesian models in your browser, with the same methods as the published analysis.

Open in the NMA lab